Source comparison
Is Tesamorelin Peptide the Same as Tesamorelin? (Full Comparison)
| Attribute | Tesamorelin | Tesamorelin Peptide | Professional Assessment ||—|—|—|| Molecular structure | 44-amino-acid GHRH analog with trans-3-hexenoic acid modification | 44-amino-acid GHRH analog with trans-3-hexenoic acid modification | Identical. No stru
This comparison does not assign a generated winner or score.
- | Attribute | Tesamorelin | Tesamorelin Peptide | Professional Assessment ||—|—|—|| Molecular structure | 44-amino-acid GHRH analog with trans-3-hexenoic acid modification | 44-amino-acid GHRH analog with trans-3-hexenoic acid modification | Identical. No structural difference || Mechanism of action | GHRHR agonist, stimulates endogenous GH release via cAMP pathway | GHRHR agonist, stimulates endogenous GH release via cAMP pathway | Identical. Same receptor binding and signaling cascade || Half-life | 26–38 minutes (subcutaneous administration) | 26–38 minutes (subcutaneous administration) | Identical. Pharmacokinetic profile unchanged || Storage requirements | Lyophilised powder: −20°C; reconstituted: 2–8°C, use within 28 days | Lyophilised powder: −20°C; reconstituted: 2–8°C, use within 28 days | Identical. Temperature stability parameters the same || Research applications | Visceral adipose reduction, GH secretion studies, metabolic research | Visceral adipose reduction, GH secretio